KRAS, TP53, CDKN2A, SMAD4, GNAS, and RNF43 were more commonly altered in PDAC/IPMN than in ITPN (P < 0.001, Fisher's exact test). This evidence concerns the gene CDKN2A and pancreatic intraductal papillary-mucinous neoplasm.